Market Exclusive

PetMed Express (NASDAQ:PETS) Files An 8-K Submission of Matters to a Vote of Security Holders

PetMed Express (NASDAQ:PETS) Files An 8-K Submission of Matters to a Vote of Security HoldersItem 5.07Submission of Matters to a Vote of Security Holders.

PetMed Express, Inc. (the “Company”, “we”, or “our”) held its Annual Meeting of Stockholders in Delray Beach, Florida on July 27, 2018. Stockholders voted on the following proposals:

1. To elect six Directors to the Board of Directors for a one-year term expiring in 2019;

2.

To conduct an advisory vote on named executive officer compensation;

3.

To ratify the appointment of RSM US LLP, as the independent registered public accounting firm for the Company to serve for the 2019 fiscal year.

The proposals presented at the Annual Meeting of Stockholders are described in more detail in the Company’s Proxy Statement on Schedule 14A that was filed with the United States Securities and Exchange Commission on June 11, 2018. As of June 1, 2018, the record date for the Annual Meeting of Stockholders, there were 20,600,605 shares of the Company’s common stock issued and outstanding and eligible to be voted at the Annual Meeting of Stockholders. A total of 18,916,846 shares were represented in person or by proxy at the Annual Meeting of Stockholders, which constituted a quorum to conduct business at the Annual Meeting of Stockholders. With a majority of the outstanding shares voting either by proxy or in person, our stockholders approved all three proposals, with voting as follows:

Proposal 1:

Shares For

Against

Witheld

Broker Non-Votes

Election of Directors:

Menderes Akdag

13,443,712 126,358 5,346,776

Leslie C.G. Campbell

13,490,950 79,120 5,346,776

Frank J. Formica

12,767,244 802,826 5,346,776

Gian M. Fulgoni

13,116,303 453,767 5,346,776

Ronald J. Korn

12,753,740 816,330 5,346,776

Robert C. Schweitzer

11,571,180 1,998,890 5,346,776

Proposal 2:

Advisory vote on the named executive officer compensation, as disclosed in the Company’s Proxy Statement for the Annual Meeting of Stockholders.

Shares For

Shares Against

Abstain

Broker Non-Votes

8,119,670 5,376,147 74,250 5,346,779

Proposal 3:

To ratify the appointment of RSM US LLP as the independent registered public accounting firm for the Company to serve for the 2019 fiscal year.

Shares For

Shares Against

Abstain

18,524,757 294,515 97,574

About PetMed Express (NASDAQ:PETS)
PetMed Express, Inc. (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies. Its products include brands of medication, such as Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Revolution and Rimadyl. It also offers additional pet supplies for sale on its Website, which are drop shipped to its customers by third parties. These pet supplies include food, beds, crates, stairs, strollers and other pet supplies. Its products included Non-Prescription Medications (Over the Counter (OTC)) and supplies, and Prescription Medications (Rx). Its customers are located in California, Florida, Texas, New York, Virginia and Georgia, among others.

Exit mobile version